If you’re planning to print pharmaceutical printing packaging, consider the benefits of flexography printing. This process is long-lasting and cost-effective, and it allows for higher-resolution and more complex prints. It also provides fast set-up and registration, and produces fewer wastes than other processes. Flexo pharmaceutical printing is environmentally-friendly, too.
High-tech Production Solution
Increasing sales of pharmaceutical drugs in the United States and Canada are driving the need for more innovative pharmaceutical packaging systems. From refillable syringes to blister packs and vials, pharmaceutical packaging needs to be continually innovated. In addition, pharmaceutical companies must comply with increasingly strict regulations to keep their products safe and compliant.
Emerging technologies are now enabling pharmaceutical manufacturers to develop new and innovative methods for pharmaceutical printing packaging. Blockchain is one such technology. This decentralized technology allows for secure, permanent, and tamper-proof transactions. Blockchain solutions provide a complete, traceable record of a product’s journey through the supply chain. They also feature a physical-digital seal that links the product to its digital twin. This makes pharmaceutical packaging even more secure and tamper-proof.
Digital Manufacturing
New developments in digital manufacturing are allowing manufacturers to keep pace with changing market demands. With the increasing demand for biopharmaceuticals, the packaging needs of pharmaceutical manufacturers are also evolving. More sophisticated equipment is required to handle complex molecules and isolate operators from the API. High-tech solutions provide the flexibility and reliability needed to increase productivity and reduce costs.
New biological drugs require unique packaging, syringes, and devices. The Gerresheimer g guide helps customers overcome these challenges and find the right solution for their needs. New biomedicines are the future for pharma, but they will also create more complex challenges for the supply chain.
Technology and market expertise are crucial for pharmaceutical manufacturers to keep pace with the changing market dynamics. The need for precision medicine has spurred changes in manufacturing processes, including the ability to produce smaller batches. With these changes, pharmaceutical companies are now able to produce pharmaceutical products as needed. This allows them to increase productivity while minimizing human errors.
Viscosity Management
Viscosity management is crucial for biopharmaceutical companies. It can affect injection time, force, ergonomics, and system reliability. Viscosity can also impact the efficiency of biopharmaceutical processes. Viscosity management strategies can help biopharmaceutical companies minimize risk and achieve the best overall product results.
The use of viscosity-management systems has several advantages over manual viscosity measurement. First of all, these systems help in maintaining optimum point-of-application temperature. But viscosity can also vary due to other factors, such as shear rate, flow conditions, and pressure. Viscosity management solutions help to reduce printing errors, as well as save time and effort.
Pharmaceutical & Personal Care
Viscosity management tools are essential for pharmaceutical and personal care industries. They ensure consistent and accurate measurements while preventing the possibility of contamination and other potential problems associated with viscous materials. They are also useful for quality assurance measurements in the laboratory. Viscosity management can help pharmaceutical manufacturers to meet customer expectations.
Understanding the flow behavior of feed materials is crucial for tailoring process conditions and selecting appropriate polymer-carriers. In addition, the addition of solid matter to polymer melts can dramatically affect the flow properties of pharmaceutical formulations and require adjustments in processing parameters. Viscosity management is an important parameter in pharmaceutical printing packaging and is considered a key factor in reproducibility of the printed structure.
Quality Control
There are a number of quality control considerations to take into account when printing pharmaceutical packaging. First, the container should be able to protect the product from environmental factors and should be suitable for the intended use. Second, the product and pack should be compatible. Compatibility trials should be carried out to ensure that both components perform optimally.
Third, pharmaceutical companies should consider Braille in their packaging, as this will help visually impaired consumers to read product labels. According to EU Directive 2001/83/EC, Braille labeling must be included on the packaging of medicines for the blind. In addition, pharmaceutical print inspections should focus on text verification and quality assurance. This is because the copy is the element of packaging that requires the most detail and time.
Pharmaceutical Companies
Lastly, pharmaceutical companies should consider using automation for quality control. Advanced technologies can help reduce the time needed for inspection and improve packaging quality. For example, modern print image control systems can check pharmaceutical labels and printed products at 600 dpi. These systems also help pharmaceutical companies improve data integrity and traceability.
In addition to using automated quality control systems, manufacturers should ensure that the entire process has a documented first piece approval. This means that any deviations must be documented and rectified as quickly as possible. In addition, all master samples must be signed and dated in duplicate. The quality department should retain one of these master samples at each working station.
Automated testing systems are increasingly common, and they allow pharmaceutical manufacturers to increase the efficiency of their processes. The systems are also easy to use and can be securely presented during subsequent audits. The user-friendly software systems can provide comprehensive quality control solutions at each stage of the production process. However, they must be created in accordance with relevant GMP and ISO 9001 guidelines. The software must also include the functions required to perform inspections.
Anti-Counterfeiting Measures
Pharmaceutical printing packaging should be protected from counterfeiting by using various anti-counterfeiting measures. One such measure is serialisation, which assigns unique identification to every product, allowing it to be traced from the manufacturer to the patient. This method has been largely effective in combating counterfeiting, but it hasn’t eliminated the problem entirely.
Colour-shifting inks can make counterfeit products difficult to replicate. They are used in large blocks, which change color depending on the angle from which they are viewed. Pharmaceutical manufacturers have begun to use these colour-shifting inks in their printing processes. These new techniques can help ensure the safety of pharmaceutical packaging by making counterfeiting very difficult.
Anti-Counterfeiting Printing Packaging
Another type of anti-counterfeiting measure is security printing. Anti-counterfeiting printing packaging protects brand names and ensures that counterfeit products do not make it into the market. This method can be passive or semi-active, and it can even use RFID to detect counterfeit products. Global demand for such packaging solutions is expected to boost the global anti-counterfeiting printing packaging market.
Despite these security solutions, counterfeit pharmaceuticals continue to be a major problem. New security techniques are being developed to fight the problem, and many agencies, including the FDA, are implementing new measures to prevent the sale of counterfeit pharmaceutical products. These new measures will undoubtedly boost the global anti-counterfeit pharmaceutical packaging market.
Sustainability
Pharmaceutical printing packaging can be a powerful tool for promoting social and environmental change. By choosing sustainable, biodegradable materials, manufacturers can help minimize their negative impact on the environment. Bio-based plastics are easy to process, use heat-resistant, and take up less energy than traditional plastics. Packaging made of sustainable materials also reduces the use of trees. Sugarcane board, hemp, and recycled cotton fiber are just a few of the sustainable alternatives.
Sustainability in pharma packaging is a major priority for most pharmaceutical manufacturers. As a result, they are using more recycled content, using energy-efficient printing equipment, and changing packaging formats to be more sustainable. These efforts are a significant step towards making the industry more sustainable. Taking these steps will help the pharma industry become more environmentally friendly while ensuring the safety of its products.
Enhance Your Company’s
Sustainable packaging in the pharmaceutical industry is an excellent way to differentiate your brand from your competitors. Not only will it enhance your company’s image among end users and customers, but it will also increase your bottom line. Sustainable packaging will not be cheap, but it can lead to greater customer and employee engagement and a stronger brand reputation. Traditionally, pharmaceutical packaging has been based on cardboard cartons. Despite the high price of these materials, they are highly durable and are an important part of the pharmaceutical industry.
By implementing sustainable packaging practices in pharmaceutical printing packaging, pharmaceutical brands can minimize their impact on the environment. For example, by reducing the size and weight of blister cards, pharmaceutical manufacturers can reduce their carbon footprint. In addition, by identifying which chemicals are used, companies can make their products safer and more information environmentally friendly. In addition, these innovations will encourage others to adopt the same methods. Sustainability in pharmaceutical printing packaging can also be a competitive advantage for pharmaceutical brands.
